亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study

沃戈宁 药理学 医学 药品 抗病毒药物 2019年冠状病毒病(COVID-19) 病毒 免疫学 内科学 中医药 传染病(医学专业) 疾病 黄芩 替代医学 病理
作者
Lu Xia,Yujing Shi,Jie Su,Thomas Friedemann,Zhenggang TAO,Yunfei Lu,Yun Ling,Ying Lv,Ronghua Zhao,Zihan Geng,Xiao-Lan Cui,Hongzhou Lu,Sven Schröder
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:85: 153390-153390 被引量:94
标识
DOI:10.1016/j.phymed.2020.153390
摘要

Shufeng Jiedu capsules (SFJDC), a patented herbal drug composed of eight medicinal plants, is used for the treatment of different viral respiratory tract infectious diseases. Based on its antiviral, anti-inflammatory and immunoregulatory activity in acute lung injury, SFJDC might be a promising candidate for the treatment of COVID-19. To evaluate the antiviral and anti-inflammatory properties and to discover the mechanism of action of SFJDC as a potential drug for the treatment of COVID-19. Furthermore, the study should determine the clinical effectiveness of SFJDC for the treatment of COVID-19. We analyzed the antiviral and anti-inflammatory effects of SFJDC in a HCoV-229E mouse model on lung index, virus load in the lung, the release of cytokines, and on T- and B-lymphocytes. The mechanism of action was further investigated by network analysis. Additionally, we investigated data from a clinical pragmatic real-world study for patients with confirmed COVID-19, to evaluate the clinical effect of SFJDC and to determine the best time to start the treatment. SFJDC significantly reduced the virus load in the lung of HCoV-229E mice (from 1109.29 ± 696.75 to 0 ± 0 copies/ml), decreased inflammatory factors IL-6, IL-10, TNF-α, and IFN-γ in the lung, and increased the amount of CD4+ and CD8+ cells in the blood compared to the model group. Network analysis revealed that SFJDC reduces the activity of NFκB via several signaling pathways. Quercetin, wogonin, and polydatin bind directly to the main protease (Mpro) of SARS-CoV-2. Clinical data showed that SFJDC, added to standard antiviral therapy (AVD), significantly reduced the clinical recovery time of COVID-19 and fatigue (from 3.55 ± 4.09 to 1.19 ± 2.28 days) as well as cough (from 5.67 ± 5.64 to 3.47 ± 3.75) days compared to AVD alone. SFJDC therapy was significantly more effective when used within the first 8 days after the onset of symptoms. SFJDC might be a promising drug for the treatment of COVID-19, but large-scale randomized, double-blinded, placebo-controlled clinical trials are needed to complement the real-world evidence. It might be beneficial to start SFJDC treatment as early as possible in suspected cases of COVID-19.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DrShiva完成签到,获得积分10
5秒前
9秒前
11秒前
12秒前
12秒前
生动的昊焱完成签到,获得积分10
14秒前
14秒前
18秒前
震动的静芙完成签到,获得积分10
18秒前
21秒前
李健的应助被Eva小飞鱼采纳,获得10
23秒前
28秒前
31秒前
31秒前
纯情的阁发布了新的文献求助10
32秒前
纯情的阁发布了新的文献求助10
32秒前
纯情的阁发布了新的文献求助10
32秒前
34秒前
35秒前
纯情的阁发布了新的文献求助10
35秒前
纯情的阁发布了新的文献求助10
36秒前
纯情的阁发布了新的文献求助10
36秒前
纯情的阁发布了新的文献求助10
36秒前
纯情的阁发布了新的文献求助10
36秒前
37秒前
纯情的阁发布了新的文献求助10
39秒前
纯情的阁发布了新的文献求助10
39秒前
纯情的阁发布了新的文献求助30
39秒前
39秒前
纯情的阁发布了新的文献求助10
39秒前
纯情的阁发布了新的文献求助10
39秒前
纯情的阁发布了新的文献求助10
40秒前
40秒前
41秒前
42秒前
42秒前
纯情的阁发布了新的文献求助10
43秒前
纯情的阁发布了新的文献求助10
43秒前
纯情的阁发布了新的文献求助10
43秒前
纯情的阁发布了新的文献求助10
43秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158792
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748395
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2551987
邀请新用户注册赠送积分活动 2471354